Esposito I - Search Results

1

Kleeff J, Whitcomb DC, Shimosegawa T, Esposito I, Lerch MM, Gress T, Mayerle J, Drewes AM, Rebours V, Akisik F, Muñoz JED, Neoptolemos JP. Kleeff J, et al. Among authors: esposito i. Nat Rev Dis Primers. 2017 Sep 7;3:17060. doi: 10.1038/nrdp.2017.60. Nat Rev Dis Primers. 2017. PMID: 28880010 Review.

2

Mast cell distribution and activation in chronic pancreatitis.

Esposito I, Friess H, Kappeler A, Shrikhande S, Kleeff J, Ramesh H, Zimmermann A, Büchler MW. Esposito I, et al. Hum Pathol. 2001 Nov;32(11):1174-83. doi: 10.1053/hupa.2001.28947. Hum Pathol. 2001. PMID: 11727255

3

Molecular mechanisms in chronic pancreatitis.

Esposito I, Friess H, Büchler MW. Esposito I, et al. Zentralbl Chir. 2001 Nov;126(11):867-72. doi: 10.1055/s-2001-19158. Zentralbl Chir. 2001. PMID: 11753795 Review.

4

The stem cell factor-c-kit system and mast cells in human pancreatic cancer.

Esposito I, Kleeff J, Bischoff SC, Fischer L, Collecchi P, Iorio M, Bevilacqua G, Büchler MW, Friess H. Esposito I, et al. Lab Invest. 2002 Nov;82(11):1481-92. doi: 10.1097/01.lab.0000036875.21209.f9. Lab Invest. 2002. PMID: 12429808 Free article.

5

Indian hedgehog signaling pathway: expression and regulation in pancreatic cancer.

Kayed H, Kleeff J, Keleg S, Guo J, Ketterer K, Berberat PO, Giese N, Esposito I, Giese T, Büchler MW, Friess H. Kayed H, et al. Among authors: esposito i. Int J Cancer. 2004 Jul 10;110(5):668-76. doi: 10.1002/ijc.20194. Int J Cancer. 2004. PMID: 15146555 Free article.

6

Localization of the human hedgehog-interacting protein (Hip) in the normal and diseased pancreas.

Kayed H, Kleeff J, Esposito I, Giese T, Keleg S, Giese N, Büchler MW, Friess H. Kayed H, et al. Among authors: esposito i. Mol Carcinog. 2005 Apr;42(4):183-92. doi: 10.1002/mc.20088. Mol Carcinog. 2005. PMID: 15754313

7

Renal cancer cell metastasis into the pancreas: a single-center experience and overview of the literature.

Wente MN, Kleeff J, Esposito I, Hartel M, Müller MW, Fröhlich BE, Büchler MW, Friess H. Wente MN, et al. Among authors: esposito i. Pancreas. 2005 Apr;30(3):218-22. doi: 10.1097/01.mpa.0000153337.58105.47. Pancreas. 2005. PMID: 15782097 Review.

8

Loss of BNIP3 expression is a late event in pancreatic cancer contributing to chemoresistance and worsened prognosis.

Erkan M, Kleeff J, Esposito I, Giese T, Ketterer K, Büchler MW, Giese NA, Friess H. Erkan M, et al. Among authors: esposito i. Oncogene. 2005 Jun 23;24(27):4421-32. doi: 10.1038/sj.onc.1208642. Oncogene. 2005. PMID: 15856026

9

Osteopontin influences the invasiveness of pancreatic cancer cells and is increased in neoplastic and inflammatory conditions.

Kolb A, Kleeff J, Guweidhi A, Esposito I, Giese NA, Adwan H, Giese T, Büchler MW, Berger MR, Friess H. Kolb A, et al. Among authors: esposito i. Cancer Biol Ther. 2005 Jul;4(7):740-6. doi: 10.4161/cbt.4.7.1821. Epub 2005 Jul 5. Cancer Biol Ther. 2005. PMID: 15970685

10

Expression analysis of PMP22/Gas3 in premalignant and malignant pancreatic lesions.

Li J, Kleeff J, Esposito I, Kayed H, Felix K, Giese T, Büchler MW, Friess H. Li J, et al. Among authors: esposito i. J Histochem Cytochem. 2005 Jul;53(7):885-93. doi: 10.1369/jhc.4A6546.2005. J Histochem Cytochem. 2005. PMID: 15995147

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

498 results

Search Page